Moreover, many eye diseases, such as nAMD and DR, were related to AD and routinely required multiple intravitreal injections (anti-VEGF treatment), facilitating multiple AH samples to observe the change rate of AD biomarkers. Here, VEGFA is linked to eye disorder.